Patent · US Active

Macrocyclic inhibitors of hepatitis C virus

US9040562B2 · kind B2 · utility

0Cited by

22References

16Claims

0Family size

Assignees

Janssen R & D Ireland · IE
MEDIVIR AB · SE

Inventors

Kenneth Alan Simmen · Tervuren, BE
Herman Augustinus De Kock · Arendonk, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Karl Magnus Nilsson · Vimmerby, SE
Bengt Bertil Samuelsson · Skärholmen, SE
Asa Annica Kristina Rosenquist · Huddinge, SE

Key dates

Filing date	May 23, 2014
Grant date	May 26, 2015
Priority date	—
Expiry date	May 23, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.